fr   en

Tableaux synoptiques (en anglais)

Parcourir par date
Rechercher par mot clé
Date: 2010-02-16
Biotech partner: Philogen (Italy)
Pharma Partner: Bayer HealthCare Manufacturing (Germany)
Type of agreement: * manufacturing
Nature of the agreement: Philogen has acquired a site located in Rosia, near Siena (Italy) from Bayer HealthCare Manufacturing. The site, located near an important area in Europe for R&D vaccine
production, will now be used by Philogen for the development of its clinical-stage anti-cancer biotech products, such as L19-SIP, L19-TNF, L19-IL2 and F16-IL2.
This transaction is the latest of a number of agreements recently executed between the Italian and the German company. In May 2009, Philogen and Bayer Schering Pharma have signed new collaborative agreements, which will allow the expansion of their joint development activities in the field of cancer radioimmunotherapy.
Financial terms of the agreement: Financial details were not disclosed.

Go back to previous page